Natural History of Depression, Bipolar Disorder and Suicide Risk
NCT06462196
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Mood disorders, such as depression and bipolar disorder, are difficult to treat. One reason is that there are no objective ways to measure how these disorders affect the body and respond to different treatments. In this study, researchers want to perform tests on people undergoing clinical care for mood disorders. The purpose is to understand the experience of receiving treatment for depression, bipolar disorder, and suicide risk. We also hope that this study will help us to predict which medications will improve thoughts of suicide.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Behavioral Symptoms
- Suicide
- Self-Injurious Behavior
- Sensory System Agents
- Analgesics
- Peripheral Nervous System Agents
- Physiological Effects of Drugs
- Anesthetics, Dissociative
- Anesthetics, General
- Anesthetics
- Central Nervous System Depressants
- Excitatory Amino Acid Antagonists
- Excitatory Amino Acid Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Ketamine
- Depression, Unipolar
- Depressive Symptoms
- Treatment Resistant Depression
- Major Depressive Disorder
- Depression, Bipolar
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 to 120 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- National Institute of Mental Health (NIMH)
- Last updated on ClinicalTrials.gov
- October 1, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- National Institutes of Health Clinical Center · Bethesda, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.